NeuroPace, Inc.
NeuroPace, Inc. (NPCE) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · NPCE · as of Sep 30, 2025
Ownership Breakdown
82
Institutional Holders
▼ 22 vs Q2
$267.50M
Total Inst. Value
▲ $16.79M vs Q2
34.09M
Shares Outstanding
freeFloat 68.35%
25.95M
13F Shares Held
▲ 3.44M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
NPCE largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
POLAR CAPITAL HOLDINGS PLC surgical & medical instruments & apparatus | 3.10M | 9.43% | 9.43% | $31.94B | Nov 14, 2025 | ▲ 3.10M |
SOLEUS CAPITAL MANAGEMENT, L.P. surgical & medical instruments & apparatus | 2.96M | 9.00% | 9.00% | $30.50B | Nov 14, 2025 | ▲ 645.0K |
ORBIMED ADVISORS LLC surgical & medical instruments & apparatus | 2.61M | 7.95% | 7.95% | $26.95B | Nov 14, 2025 | — held |
MORGAN STANLEY surgical & medical instruments & apparatus | 2.55M | 7.75% | 7.75% | $26.25B | May 27, 2026 | ▼ 38.9K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 2.42M | 7.35% | 7.35% | $24.92B | Nov 12, 2025 | ▲ 97.5K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 1.44M | 4.37% | 4.37% | $14.80B | Nov 7, 2025 | ▲ 66.6K |
FIRST LIGHT ASSET MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.36M | 4.14% | 4.14% | $14.02B | Nov 14, 2025 | ▼ 20.3K |
ARMISTICE CAPITAL, LLC surgical & medical instruments & apparatus | 1.30M | 3.95% | 3.95% | $13.38B | Nov 17, 2025 | ▲ 145.7K |
KENT LAKE PR LLC surgical & medical instruments & apparatus | 1.00M | 3.04% | 3.04% | $10.31B | Nov 14, 2025 | ▲ 75.0K |
DRIEHAUS CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 939.5K | 2.86% | 2.86% | $9.69B | Nov 14, 2025 | ▼ 65.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
28
Increased
+4.96M shares4
New Positions
first time holders12
Decreased
−205.6K shares0
Sold Out
fully exitedNet shares change (top 50)
+4.76M
+4.96M / −205.6K
Net new holders
+20
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
NPCE insider trading · insider activity
Source: SEC Form 4
18
Buy transactions
3
Sell transactions
6.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Huennekens R Scott director | Jun 5, 2026 | Award | 5,368 | $15.74 | $84.5K | 5.4K | Form 4 ↗ |
Huennekens R Scott director | Jun 5, 2026 | Award | 2,890 | — | — | 2.9K | Form 4 ↗ |
Fischer Frank M director | Jun 5, 2026 | Award | 2,890 | — | — | 598.1K | Form 4 ↗ |
Fischer Frank M director | Jun 5, 2026 | Award | 5,368 | $15.74 | $84.5K | 5.4K | Form 4 ↗ |
Geiger Uri director | Jun 5, 2026 | Award | 2,890 | — | — | 17.7K | Form 4 ↗ |
Geiger Uri director | Jun 5, 2026 | Award | 5,368 | $15.74 | $84.5K | 5.4K | Form 4 ↗ |
Kumar Rakhi director | Jun 5, 2026 | Award | 2,890 | — | — | 22.1K | Form 4 ↗ |
Kumar Rakhi director | Jun 5, 2026 | Award | 5,368 | $15.74 | $84.5K | 5.4K | Form 4 ↗ |
Ryan Renee director | Jun 5, 2026 | Award | 5,368 | $15.74 | $84.5K | 5.4K | Form 4 ↗ |
Ryan Renee director | Jun 5, 2026 | Award | 2,890 | — | — | 2.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
NeuroPace, Inc. (NPCE) is primarily owned by institutional investors, who hold approximately 76.1% of total shares outstanding. Company insiders own approximately 31.65%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of NeuroPace, Inc. is POLAR CAPITAL HOLDINGS PLC, holding approximately 3.10 million shares — equal to 9.43% of outstanding shares — as of September 30, 2025.
A total of 82 institutional investors currently hold NPCE stock, with a combined institutional value of approximately $267,500,978 as of the most recent 13F filing period.
Frequently asked questions
NPCE ownershipNeuroPace, Inc. (NPCE) is primarily owned by institutional investors, who hold approximately 76.1% of shares. The largest shareholder is POLAR CAPITAL HOLDINGS PLC with a 9.43% stake. Company insiders hold 31.65%. Data sourced from SEC Form 13F as of September 30, 2025.